Vygenerované: 19.01.2026 23:05:18
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Delhi Pharma Firm Owner Arrested in Major Drug Trafficking Case Jammu: In a significant breakthrough against narcotics trafficking, the Anti-Narcotics Task Force (ANTF) of the Jammu and Kashmir Police has apprehended the owner of a Delhi-based pharmaceutical company for his alleged involvement in a wide-ranging drug trafficking operation in the Union Territory According to a recent media report in News Point, the accused has been identified as Jatish Babbar, son of Harish Babbar, and a resident of South Delhi, who owns a pharmaceutical company Police stated that Babbar was taken into custody on charges related to multiple cases under the Narcotic Drugs and Psychotropic Substances (NDPS) Act following sustained investigation by the ANTF.
Doplnenie: According to officials, Babbar’s name already featured in three separate NDPS cases registered at the ANTF police station in Jammu — FIR No.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry CDSCO, DoP Told to Find Workable Solution on Revised Schedule M GMP Concerns New Delhi: Union Health Minister Jagat Prakash (JP) Nadda has directed India's drug regulator and the Department of Pharmaceuticals (DoP) to devise a workable solution to address concerns raised by pharmaceutical industry groups regarding the implementation of the revised Schedule M norms under the Drugs and Cosmetics Act Schedule M prescribes Good Manufacturing Practices (GMP) standards that drug manufacturers must follow, including requirements such as a prompt product recall system for products known or suspected to be defective Industry representatives have argued that the revised compliance norms are stringent and operationally challenging, especially for smaller and medium-sized manufacturers.
Doplnenie: Officials stated that Nadda has engaged in detailed discussions with industry stakeholders, including meetings with representatives of Laghu Udyog Bharti (LUB) -an RSS affiliate representing small and micro enterprises.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Alcon India Gets Rs 25 Cr Tax Relief as ITAT Bengaluru Quashes Advertising, Marketing and Promotion Adjustments New Delhi: In a significant ruling with implications for multinational subsidiaries operating in India, the Income Tax Appellate Tribunal (ITAT), Bengaluru Bench, has allowed the appeal filed by Alcon Laboratories (India) Private Limited, setting aside major transfer pricing and expense disallowance additions made by the Income Tax Department for Assessment Year 2018-19 The dispute revolved around whether advertising, marketing and promotion (AMP) expenses, IT support services, business support services, and certain seminar and sponsorship expenses incurred by Alcon India could be treated as international transactions benefiting its foreign associated enterprise (AE) and consequently subjected to transfer pricing adjustments Alcon Laboratories (India) Pvt.
Doplnenie: , a subsidiary of the global Alcon group, is engaged in the distribution of ophthalmic surgical equipment, lenses, spare parts and pharmaceutical products in India, along with providing related maintenance and support services.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Amid Global Headwinds, Brazil and Nigeria Fuel India's Pharma Export Growth New Delhi: Brazil and Nigeria are emerging as key export destinations for amid global economic uncertainties, according to the commerce ministry data "These markets reflect rising healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India's role as a preferred supplier to high growth demand intensive regions," an official said Nigeria emerged as one of the fastest growing destinations, adding Rs 179 million in exports and contributing over 14 per cent to the total export growth during the first eight months of this fiscal year.
Doplnenie: "These markets reflect rising healthcare access, expanding public procurement, and growing reliance on Indian generics, reinforcing India's role as a preferred supplier to high growth demand intensive regions," an official said.
Súhrn: - Home - Medical news & Guidelines - Anesthesiology - Cardiology and CTVS - Critical Care - Dentistry - Dermatology - Diabetes and Endocrinology - ENT - Gastroenterology - Medicine - Nephrology - Neurology - Obstretics-Gynaecology - Oncology - Ophthalmology - Orthopaedics - Pediatrics-Neonatology - Psychiatry - Pulmonology - Radiology - Surgery - Urology - Laboratory Medicine - Diet - Nursing - Paramedical - Physiotherapy - Health news - Fact Check - Bone Health Fact Check - Brain Health Fact Check - Cancer Related Fact Check - Child Care Fact Check - Dental and oral health fact check - Diabetes and metabolic health fact check - Diet and Nutrition Fact Check - Eye and ENT Care Fact Check - Fitness fact check - Gut health fact check - Heart health fact check - Kidney health fact check - Medical education fact check - Men's health fact check - Respiratory fact check - Skin and hair care fact check - Vaccine and Immunization fact check - Women's health fact check - AYUSH - State News - Andaman and Nicobar Islands - Andhra Pradesh - Arunachal Pradesh - Assam - Bihar - Chandigarh - Chattisgarh - Dadra and Nagar Haveli - Daman and Diu - Delhi - Goa - Gujarat - Haryana - Himachal Pradesh - Jammu & Kashmir - Jharkhand - Karnataka - Kerala - Ladakh - Lakshadweep - Madhya Pradesh - Maharashtra - Manipur - Meghalaya - Mizoram - Nagaland - Odisha - Puducherry - Punjab - Rajasthan - Sikkim - Tamil Nadu - Telangana - Tripura - Uttar Pradesh - Uttrakhand - West Bengal - Medical Education - Industry Nearly 49% Pharmacist Posts Vacant in Haryana Govt Hospitals, Patient Safety at Risk New Delhi: Patients' safety in Haryana's government hospitals is facing a serious risk as the state grapples with an acute shortage of pharmacists, with 568 of the 1163 sanctioned posts currently vacant, triggering concerns over the safe dispensing of doctor-prescribed medicines Health experts warn that this situation amounts to playing with patients’ lives At several Primary Health Centres (PHCs) and Community Health Centres (CHCs), medicines are reportedly being dispensed in the absence of registered pharmacists.
Doplnenie: According to media reports by Amar Ujala, the situation is especially grim in major districts such as Karnal, Sirsa and Ambala.
Súhrn: / postdoktorand Postdoctoral researcher in Tumor microenvironment & metabolism Postdoctoral researcher in Tumor microenvironment & metabolism Hodnocení: tohle není dobré drobné nedostatky dobrý velmi dobrý vynikající děkujeme za Vaše hodnocení spravovat Univerzita Karlova Kontakty SIS Mail UK Předpisy Hledaný výraz Hledat Přihláška E-shop linkedin bluesky facebook youtube instagram spotify EN O fakultě Zaměstnanci Úřední deska Média a veřejnost Další vzdělávání Učitelé SŠ Kontakty Home Uchazeči Studenti Doktorandi Absolventi Věda a výzkum Aktuality Doktorské studijní programy Předměty pro doktorandy Přijímací řízení Studium Školitelé Zakončení studia Nabídka Ph / postdoktorand Formuláře Chcete zůstat v obraze? Přihlaste se k odběru časopisu Jednička a infolistů! Váš email Přihlásit se Pomůžeme vám Potřebujete pomoc nebo informace a nevíte přesně na koho se obrátit? Kontaktujte nás LF1 Doktorandi Nabídka Ph.
Doplnenie: Toto je automaticky generovaný súhrn článku.